Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.
about
Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancerRole of microRNAs in chemoresistanceNon-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer MetabolismNotch signaling in prostate cancer: refining a therapeutic opportunityInsights into Chemoresistance of Prostate CancerUncovering the roles of miRNAs and their relationship with androgen receptor in prostate cancerMicroRNAs targeting prostate cancer stem cellsA dual yet opposite growth-regulating function of miR-204 and its target XRN1 in prostate adenocarcinoma cells and neuroendocrine-like prostate cancer cellsAmygdala-dependent fear memory consolidation via miR-34a and Notch signaling.Network analysis of ChIP-Seq data reveals key genes in prostate cancer.MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.A potential regulatory loop between Lin28B:miR‑212 in androgen-independent prostate cancer.The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cellsThe impact of microRNA expression on cellular proliferationRole of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.The role of microRNAs in the regulation of cancer stem cells.miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma.MicroRNA-34a regulates liver regeneration and the development of liver cancer in rats by targeting Notch signaling pathwayMicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling.Obesity, Diabetes and Cancer: A Mechanistic PerspectiveMicroRNAs and drug resistance in prostate cancers.Mir-34: a new weapon against cancer?The Secret Role of microRNAs in Cancer Stem Cell Development and Potential Therapy: A Notch-Pathway ApproachKRT6B, a key mediator of notch signaling in honokiol-induced human hepatoma cell apoptosismiRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells.Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms.Notch1/3 and p53/p21 are a potential therapeutic target for APS-induced apoptosis in non-small cell lung carcinoma cell lines.Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.Molecular and cellular mechanisms of castration resistant prostate cancer.
P2860
Q26739708-F39783B8-29B7-4460-B491-0CEF65E09CB7Q26770485-EE33B7D2-5D49-403F-B473-E6FC00475952Q26774456-E58B7D50-D14D-4029-BE0B-B78A9E3C9C11Q26777624-0515906E-0EDA-4090-83C8-3C316ADC48CAQ26795589-11A4BFD1-5CF7-4960-AFE0-1B8F5AD6A463Q27014171-FDBADD07-CB61-427A-BB47-B7B3C5FDA73CQ28081039-8122D56D-D2E0-4E9B-986E-E69FA3475AA2Q28573536-0BB3DDB1-88B7-4AE1-A3C7-5A4D58AA1E18Q30587469-C5FEDE5F-83CB-4DF6-BC6D-8AEA0094DE31Q30847259-F016F76C-FDA4-48F0-9189-E48BFA179F03Q33785102-C99B6834-CFD6-4B11-A22D-BD398DB0751EQ34432845-09AAA8F7-F7EB-4096-9B18-741EDB06B19DQ35000256-BC0C51FE-0846-429A-BF0B-24EB62E8B13AQ36367578-7ED19622-E6B8-4BC0-AF0A-8647818BA4BBQ36844904-DB1DD093-70B1-4BBD-B056-852CD8A57F56Q37189513-A903D7CD-E16B-4B5E-98A7-62D40F8E1EDAQ37428403-54425055-ECEF-402A-9F49-7EA7BBBE22ABQ37596868-AEE12A47-4ED4-405C-B99D-2FE4B077C15FQ37706591-F5888C8C-D5DE-4E19-95BD-A4BDBCF6FD9CQ37716420-DA8DFA7E-C1C0-4188-81D8-0D9D83C4371DQ37730336-F3845DAA-1B77-4471-A2F2-9F35363F6A56Q38205266-551753E4-8B15-4104-AC62-37D000D01CBCQ38253374-6E88DFFE-6C5A-4A00-94ED-15DCF0DFDA39Q38365386-9A1EDE37-DE17-4B07-A62C-56727D4EC319Q38814986-79A25B52-9E13-47F4-B118-CF3EE20D1A55Q38987842-48C426A5-E637-4B06-80A1-3CEE0DE58CFBQ39449489-25FB9C7D-BE50-41A5-AB00-3E7E376E868DQ39907903-6985D469-2E0E-49ED-86F2-780302D535F1Q41906886-0BCB9A49-EE1E-46B3-8278-5E10478C230EQ47098499-99BF3D6D-98CE-4384-81C8-5DE33A3A2F0EQ52608488-3CB7CA95-DF90-452A-A976-E5E9F3B8E1C3
P2860
Inactivation of AR and Notch-1 signaling by miR-34a attenuates prostate cancer aggressiveness.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@ast
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@en
type
label
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@ast
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@en
prefLabel
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@ast
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@en
P2093
P2860
P1476
Inactivation of AR and Notch-1 ...... rostate cancer aggressiveness.
@en
P2093
Dejuan Kong
Fazlul H Sarkar
Lyna Azzouz
Maria Kashat
Shaan H Sarkar
P2860
P304
P407
P577
2012-10-10T00:00:00Z